Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for HTG Molecular Diagnostics, Inc. (HTGM : NSDQ)
 
 • Company Description   
HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Its products include HTG Edge System, HTG Edge Assays and HTG Assay Direct. HTG Molecular Diagnostics, Inc. is headquartered in Tucson, Arizona.

Number of Employees: 88

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.68 Daily Weekly Monthly
20 Day Moving Average: 201,666 shares
Shares Outstanding: 8.59 (millions)
Market Capitalization: $5.81 (millions)
Beta: 1.99
52 Week High: $6.98
52 Week Low: $0.55
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -40.68% -35.27%
12 Week -68.25% -66.58%
Year To Date -87.52% -85.46%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3430 E. GLOBAL LOOP
-
TUCSON,AZ 85706
USA
ph: 877-289-2615
fax: 520-547-2837
None http://www.htgmolecular.com
 
 • General Corporate Information   
Officers
John L. Lubniewski - President; Chief Executive Officer and Director
Ann F. Hanham - Chairman
Shaun D. McMeans - Senior Vice President; Chief Financial Officer; Tr
Laura L. Godlewski - Senior Vice President of Finance and Administratio
Harry A. George - Director

Peer Information
HTG Molecular Diagnostics, Inc. (ABMD)
HTG Molecular Diagnostics, Inc. (DMDS)
HTG Molecular Diagnostics, Inc. (CPWY.)
HTG Molecular Diagnostics, Inc. (EQUR)
HTG Molecular Diagnostics, Inc. (ECIA)
HTG Molecular Diagnostics, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 40434H203
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 8.59
Most Recent Split Date: 11.00 (0.07:1)
Beta: 1.99
Market Capitalization: $5.81 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.49 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.40 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.46
Price/Cash Flow: -
Price / Sales: 0.67
EPS Growth
vs. Year Ago Period: -1.25%
vs. Previous Quarter: -17.39%
Sales Growth
vs. Year Ago Period: -17.42%
vs. Previous Quarter: -58.81%
ROE
03/31/22 - -146.67
12/31/21 - -122.28
09/30/21 - -109.04
ROA
03/31/22 - -61.69
12/31/21 - -53.32
09/30/21 - -49.07
Current Ratio
03/31/22 - 2.99
12/31/21 - 2.73
09/30/21 - 3.93
Quick Ratio
03/31/22 - 2.75
12/31/21 - 2.53
09/30/21 - 3.64
Operating Margin
03/31/22 - -232.97
12/31/21 - -207.90
09/30/21 - -204.62
Net Margin
03/31/22 - -217.13
12/31/21 - -192.51
09/30/21 - -188.70
Pre-Tax Margin
03/31/22 - -216.89
12/31/21 - -192.24
09/30/21 - -188.34
Book Value
03/31/22 - 1.31
12/31/21 - 1.37
09/30/21 - 2.01
Inventory Turnover
03/31/22 - 1.92
12/31/21 - 1.99
09/30/21 - 1.96
Debt-to-Equity
03/31/22 - 0.36
12/31/21 - 0.50
09/30/21 - 0.42
Debt-to-Capital
03/31/22 - 26.42
12/31/21 - 33.24
09/30/21 - 29.76
 

Powered by Zacks Investment Research ©